389 related articles for article (PubMed ID: 31075269)
1. Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation.
Lu AZ; Abo R; Ren Y; Gui B; Mo JR; Blackwell D; Wigle T; Keilhack H; Niepel M
Biochem Pharmacol; 2019 Sep; 167():97-106. PubMed ID: 31075269
[TBL] [Abstract][Full Text] [Related]
2. Small-Molecule Inhibitors of PARPs: From Tools for Investigating ADP-Ribosylation to Therapeutics.
Kirby IT; Cohen MS
Curr Top Microbiol Immunol; 2019; 420():211-231. PubMed ID: 30242511
[TBL] [Abstract][Full Text] [Related]
3. Forced Self-Modification Assays as a Strategy to Screen MonoPARP Enzymes.
Wigle TJ; Church WD; Majer CR; Swinger KK; Aybar D; Schenkel LB; Vasbinder MM; Brendes A; Beck C; Prahm M; Wegener D; Chang P; Kuntz KW
SLAS Discov; 2020 Mar; 25(3):241-252. PubMed ID: 31855104
[TBL] [Abstract][Full Text] [Related]
4. Chemical genetic methodologies for identifying protein substrates of PARPs.
Rodriguez KM; Cohen MS
Trends Biochem Sci; 2022 May; 47(5):390-402. PubMed ID: 34366182
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms governing PARP expression, localization, and activity in cells.
Sanderson DJ; Cohen MS
Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):541-554. PubMed ID: 32962438
[TBL] [Abstract][Full Text] [Related]
6. PARPs and ADP-ribosylation in RNA biology: from RNA expression and processing to protein translation and proteostasis.
Kim DS; Challa S; Jones A; Kraus WL
Genes Dev; 2020 Mar; 34(5-6):302-320. PubMed ID: 32029452
[TBL] [Abstract][Full Text] [Related]
7. A Potent and Selective PARP11 Inhibitor Suggests Coupling between Cellular Localization and Catalytic Activity.
Kirby IT; Kojic A; Arnold MR; Thorsell AG; Karlberg T; Vermehren-Schmaedick A; Sreenivasan R; Schultz C; Schüler H; Cohen MS
Cell Chem Biol; 2018 Dec; 25(12):1547-1553.e12. PubMed ID: 30344052
[TBL] [Abstract][Full Text] [Related]
8. A Simple, Sensitive, and Generalizable Plate Assay for Screening PARP Inhibitors.
Kirby IT; Morgan RK; Cohen MS
Methods Mol Biol; 2018; 1813():245-252. PubMed ID: 30097873
[TBL] [Abstract][Full Text] [Related]
9. In Vitro and Cellular Probes to Study PARP Enzyme Target Engagement.
Wigle TJ; Blackwell DJ; Schenkel LB; Ren Y; Church WD; Desai HJ; Swinger KK; Santospago AG; Majer CR; Lu AZ; Niepel M; Perl NR; Vasbinder MM; Keilhack H; Kuntz KW
Cell Chem Biol; 2020 Jul; 27(7):877-887.e14. PubMed ID: 32679093
[TBL] [Abstract][Full Text] [Related]
10. Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro.
Lin KY; Huang D; Kraus WL
Methods Mol Biol; 2018; 1813():91-108. PubMed ID: 30097863
[TBL] [Abstract][Full Text] [Related]
11. Identification of Protein Substrates of Specific PARP Enzymes Using Analog-Sensitive PARP Mutants and a "Clickable" NAD
Gibson BA; Kraus WL
Methods Mol Biol; 2017; 1608():111-135. PubMed ID: 28695507
[TBL] [Abstract][Full Text] [Related]
12. The impact of PARPs and ADP-ribosylation on inflammation and host-pathogen interactions.
Fehr AR; Singh SA; Kerr CM; Mukai S; Higashi H; Aikawa M
Genes Dev; 2020 Mar; 34(5-6):341-359. PubMed ID: 32029454
[TBL] [Abstract][Full Text] [Related]
13. Detecting Protein ADP-Ribosylation Using a Clickable Aminooxy Probe.
Morgan RK; Cohen MS
Methods Mol Biol; 2017; 1608():71-77. PubMed ID: 28695504
[TBL] [Abstract][Full Text] [Related]
14. PARP7 and Mono-ADP-Ribosylation Negatively Regulate Estrogen Receptor α Signaling in Human Breast Cancer Cells.
Rasmussen M; Tan S; Somisetty VS; Hutin D; Olafsen NE; Moen A; Anonsen JH; Grant DM; Matthews J
Cells; 2021 Mar; 10(3):. PubMed ID: 33799807
[
